These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31699501)

  • 41. Validation of alternative methods for toxicity testing.
    Bruner LH; Carr GJ; Curren RD; Chamberlain M
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 4R concept for the safety testing of immunobiologicals.
    Cussler K
    Dev Biol Stand; 1999; 101():121-6. PubMed ID: 10566784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Summary: EU standards measurements and testing project PL95-3407. Development of a standardised in vitro methodology for hepatic and renal toxicity testing.
    Hartung T
    Altern Lab Anim; 2001; 29(4):493-5. PubMed ID: 11565511
    [No Abstract]   [Full Text] [Related]  

  • 45. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expert opinions on the acceptance of alternative methods in food safety evaluations: Formulating recommendations to increase acceptance of non-animal methods for kinetics.
    Punt A; Bouwmeester H; Schiffelers MWA; Peijnenburg AACM
    Regul Toxicol Pharmacol; 2018 Feb; 92():145-151. PubMed ID: 29196030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uncertainty of testing methods--what do we (want to) know?
    Paparella M; Daneshian M; Hornek-Gausterer R; Kinzl M; Mauritz I; Mühlegger S
    ALTEX; 2013; 30(2):131-44. PubMed ID: 23665803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V
    Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
    [No Abstract]   [Full Text] [Related]  

  • 50. Hunting for animal alternatives.
    Roush W
    Science; 1996 Oct; 274(5285):168-71. PubMed ID: 8927974
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of integrated testing strategies for REACH: motivation, background and introduction. Preface.
    Cronin MT; Garrod JF; Balls M
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():i-iii. PubMed ID: 19130698
    [No Abstract]   [Full Text] [Related]  

  • 52. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 53. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory harmonization--a vaccine industry perspective.
    Goodrich TD
    Dev Biol Stand; 1997; 90():355-61. PubMed ID: 9270864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract]   [Full Text] [Related]  

  • 56. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Replacement of dogs as research animals for the approval testing of plant protection products].
    Box RJ
    ALTEX; 2006; 23(1):24-7. PubMed ID: 16477345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Humane endpoints for laboratory animals used in regulatory testing.
    Stokes WS
    ILAR J; 2002; 43 Suppl():S31-8. PubMed ID: 12388849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
    Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
    Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
    [No Abstract]   [Full Text] [Related]  

  • 60. Nonclinical Safety Testing of RNA Vaccines.
    Hager G
    Methods Mol Biol; 2017; 1499():253-272. PubMed ID: 27987155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.